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.w: . ABSTRACT 
The fatty acid composition of plasma membrane fractions of 
mammary adenocarcinomas from Strong A female mice fed diets 
varying in the amounts of linoleic and stearic acid were studied. 
Studies have indicated that linoleic acid is a tumor promoter and 
stearic acid is a tumor inhibitor. Studies have also shown that 
the plasma membrane plays an important role in the cell's 
responses to growth factors and in the development of the tumor. 
The effects of varying amounts of dietary 18:0 and 18:2 on 
the plasma membrane were studied. The purpose of the project was 
to determine the effects of these dietary fatty acids on the 
concentration of fatty acids in the plasma membrane. 
The Strong A mice were fed a high fat (15%) or low fat (5%) 
diet. The high fat diets were: SA-1 (13.2% 18:0, 0.8% 18:2), SA-
4 (10.3% 18:0, 3.0% 18:2), and SAF (0.4% 18:0, 11.4% 18:2). The 
low fat diets were: STOCK (0.3% 18:0, 1.5% 18:2) and CO (0.1% 
18:0, 3.0% 18:2). 
A decrease in linoleic acid content was noted in all 
membranes except for the large tumors from mice fed the SAF diet 
which contained 3.5% as compared to 2.7% linoleic acid in stock 
tumors. There was also a very large increase in the amount of 
18:0 in the SA-4 large (24.1%) and small (16.9%) as compared to 
8.1% for the stock tumors. In the rest of the dietary groups 
there was not a significant difference in the amount of 18:0 as 
compared to the stock, although there was a small increase in each 
diet. 
1 
INTRODUCTION 
It is known that fats are promoters of mammary tumors. It is 
also known that plasma membranes play an important role in the 
cell's responses to growth factors and in the development of the 
tumor. Recently the membrane has been considered a serious 
location for antineoplastic therapy. By altering the structure of 
the membrane, Burns and spector were able to change tumors' 
responses to various environments which implies that membrane 
therapy is possible. 
Many studies have examined the effects of various poly-
unsaturated fats on the incidence and growth of tumors. It 
has been discovered that there is an increase in proliferation of 
cancer with an increase in polyunsaturated fat in the diet. It 
was also discovered that diets rich in saturated fatty aids caused 
a decrease in the proliferation of cancer. Specifically, linoleic 
acid, which is a polyunsaturated fatty acid, has been shown to be 
a tumor promoter. Stearic acid, on the other hand, is a saturated 
fatty acid and has been shown to inhibit tumor production. 
Although it is known that polyunsaturated fat causes an 
increase in tumor production, little work has been done on the 
effects of specific fatty acids on the plasma membrane. The 
effects of various amounts of linoleic acid and stearic acid in 
the diet have been studied, but not their effects on the plasma 
membrane. In this investigation the effects of varying amounts of 
linoleic acid and stearic acid, in isocaloric diets, on plasma 
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membranes were studied. 
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LITERATURE REVIEW 
History of the Cell Membrane 
The membrane of a cell plays a much more important role than 
just compartmentalization of the cell. It controls the movement 
of substances into and out of the cell, plays an important role in 
detection of external signals and serves as the locus of specific 
functions (1). Charles Overton, in the 1890's, was aware that 
cells seemed to be enveloped by some sort of selectively permeable 
layer that allowed the passage of some substances but not others. 
Working with cells of plant root hairs, Overton found that lipid-
soluble substances penetrated readily into cells. From this study 
Overton concluded that the solublility properties of,the cell 
membrane resembled those of fatty oil (1). 
Another important advance came in the early 1900's when 
Langmuir studied the behavior of amphipathic phospholipids by 
spreading them out as a thin layer on a water surface. By 
dissolving the lipids in benzene and then allowing the benzene to 
evaporate, Langmuir developed the first lipid monolayer (1). In 
1925, Gorter and Grendel used Langmuirs monolayer technique along 
with lipids they extracted from red blood cells and determined 
that ther were two monolayers or one lipid bilayer (1). Unto this 
day the lipid bilayer is considered the basic structure of all 
membranes and serves as a permeablility to most water-soluble 
3 
substances. It is from the results of their research that new 
insights have been developed on how to stop the proliferation of 
cancerous cells. 
Biochemical Aspects 
Linoleic acid, a polyunsaturated fatty acid, has been 
identified as a promoter of tumorogenesis and stearic acid, a 
saturated fatty acid, has been shown to increase the latency 
period (2). Erickson et. al. (3) found that the number of 
antibody forming cells appear to be inversely related to the levels 
of linoleic acid. His study dealt with the effects of dietary fat 
on the antibody response to a T-dependent antigen. On the other 
hand, Das et. al. (4) reported that polyunsaturated fats inhibit 
normal and tumor cell growth in vitro. The report also mentions 
that polyunsaturated fatty acids induced growth inhibition and 
autotoxicity to tumor cells by enhancing free radical generation. 
Free radicals can initiate lipid peroxidation and are toxic to 
tumor cells. Corwin et. al. (5) also found that tumorogenicity of 
their murine cell line increased as the polyunsaturated fatty acid 
level decreased. Yet, another strain which was grown on lipid 
depleted media showed a decrease in tumorogenicity with any 
decrease in polyunsaturated fatty acid level. 
Kamiyama et. al. (6) found that there may be a unique tumor 
surface marker with chemical and immunological properties in 
common with those isolated directly from human breast 
adenocarcinomas. The surface marker was discovered by isolation 
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of a tumor surface antigen which induced the formation of 
antibodies which recognized the surface marker by the immune 
adherence hemagglutination test (6). Pitelka et. al. (7) found 
that the mouse mammary tumor cells in primary culture virtually 
always are contact inhibited. Pitelka's group also showed that 
one of their transplanted tumor lines, which formed far fewer 
junctions than typical mammary carcinoma and does not show contact 
inhibition in culture, is not exceptionally invasive and has not 
metastasized. 
Reasearch done by Burns and Spector (8) has shown that fatty 
acid modification of tumor membranes may make them more 
susceptible or sensitive to clinically useful therapeutic methods. 
Fatty acid modification is possible due to the fact that tumors 
derive most of their fatty acids from the extracellular fluid when 
an adequate supply of lipid is available. The fatty acids of 
cultured cells are modified by changing the type and amount of 
lipid contained in the growth medium. The fatty acids in the 
extracellular fluid are utilized preferentially and de novo 
synthesis is suppressed (8). Studies done by Bertino (9) show 
that some drugs that slow or stop cancer cells from proliferating 
are doing so by effecting the cell membrane. Bertino also states 
that cell membranes reflect the tissue of origin and therefore, 
they may have specialized features that cam be exploited 
therapeutically. Cooper (10) mentions that it is possible that 
changes in fluidity may lead to susceptibility of disease. 
findings lead to the fact that the cell membrane may be a 
plausible target for antineoplastic therapy. 
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Dietary Aspects 
In a study done by Thomas (11), it was estimated that 30 
percent of cancers may be caused by dietary factors. Thomas also 
stated that breast cancer is known to be estrogen dependent and 
estrogen production is related to obesity which is related to 
excess dietary fat. A study done by Chan and Cohen (12) showed 
that mammary tumor cell proliferation is stimulated when the 
prolactin:estrogen ratio is high and is inhibited when the ratio 
is low. It was also shown that chronic high fat intake elevated 
serun prolactin levels, which elevates the prolactin:estrogen 
ratio, and thereby promotes mammary tumor cell growth. In a study 
done by Sakaguchi et. al. (13), rats were fed a 5% fat diet 
containing linoleate or stearate to measure affects of dietary fat 
on colon carcinogenesis. The rats were given azoxymethane as a 
carcinogen and it was discovered that the rats on the unsaturated 
diet had significantly more colon cancer. 
Becker and Bruce (14) demonstrated that the dietary level of 
essential fatty acids influences the utilization and metabolism of 
linoleic acid. There study showed that animals fed low essential 
fatty acids retained 50% of the linol~ic acid ingested as compared 
to 10-15% linoleic acid retained in normal and high essential 
fatty acid rats. It was also shown that there was a large amount 
of stearic acid retained in the low essential fatty acid diet mice 
and normal essential fatty acid diet mice and a large amount of 
linoleic acid retained in the high essential fatty acid diet mice. 
Siquel and Maclure (15) found that there was a decrease in the 
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amount of linoleic acid in individuals with essential fatty acid 
deficiency. Their study also showed an increase in oleic acid 
which shows the synthesis from saturated fatty acid precursers. A 
study done by Field et. al. (16) found that subjects with higher 
intakes of saturated fatty acids exhibited increased levels of 
total saturated fatty acids and decreased polyunsaturated fatty 
acids in adipose tissue. Field et. al. also stated that adipose 
tissue linoleic acid content is related to the nature of fat 
consumed. 
Plasma membranes of cells are affected by dietary intake. 
Carlson et. al. (17) showed that with increased linoleic acid in 
the diet there tended to be a higher percent of linoleic acid in 
the red blood cell membrane. In a study done by Alan and Alan 
(18), it was discovered that membranes of rats that were essential 
fatty acid deficient were less fluid. Also, when these EFA 
deficient mice were fed a control diet for six weeks the fatty 
acid composition of membrane lipids was restored to normal 
values. This study illustrated the fact that diet does have an 
effect on plasma membranes. Burns and spector (8) also 
illustrated this fact. In their study, they found that when a 
diet rich in saturated fat was fed to mice there was an increase 
in oleic acid (18:1) and a decrease in linoleic acid (18:2) within 
the membrane. Burns and spector also found that there was a 
decrease in carrier-mediated activity in the mice fed a 
polyunsaturated fat. 
Burns and spector's (8) study indicated that lipid 
modification may have an effect on membrane function. 
very important due to the fact that membrane fatty acid 
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This is 
modifications may be achieved, either by growth of a tumor in 
animals fed different fat supplemented diets or in a culture by 
varying the lipids added to the medium. This ability to modify 
membranes may be a positive influence in the halting of 
proliferation of cancerous cells. 
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PROCEDURES AND METHODS 
Materials 
KHP04, sucrose, CaC12, NaHC03, acetone, nitrogen, acetic 
acid, KOH, methanol, HCL, distilled water, ether, hexane, KCl, 
Na2S04, carbitol, diazold, and all glassware required were 
obtained from Dr. Alice Bennett's research facilities. 
Animals 
The mice used for this project were obtained by Dr. Bennett 
from the late Dr. Gordon L. Rosene, Department of Physiology, Ball 
State University. The mice originated during the summer of 1921 
when Strong obtained two albino mice while working at the Carnegie 
Institution of Washington, Spring Harbor, Long Island. These mice 
were mated and the stock was continued by brother-to-sister 
matings (19). 
Until the summer of 1927, all the mice were used for 
transplantation studies on tumors. But, in 1927 several different 
albino mice developed spontaneous carcinoma and it was decided 
that transplantation studies should be discontinued so that 
primary tumors could be concentrated upon (19). 
The mice used for this project are called strain A/St mice 
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which refers to Strong A mice. The mice were housed in plastic 
cages in a controlled environment (21-24 c; 12hr light:dark 
cycle). They were fed five diets: SAF (11.4% linoleic acid, .4% 
stearic acid), SA-4 (3.0% linoleic acid, 10.3% stearic acid), SA-1 
(0.8% linoleic acid, 13.2% stearic acid), CO (3.0% linoleic acid, 
0.1% stearic acid) and ST (1.5% linoleic acid, 0.3% stearic acid). 
Preparation of Diets 
The special diets fed the mice were prepared in such a way 
that they contained the same percentage of protein per gram of food. 
All other factors except the percentage of fat remained constant. 
The caloric difference in the amount of fat in each of the diets 
was compensated for by the addition of either sucrose or calorie 
free cellulose. The safflower oil and stearic acid diet were 
prepared from either a fat free diet purchased from U.S. 
Biochemicals or from a fat free base prepared from a mixture of 
basic ingredients and purified fat. The corn oil diet was 
prepared from a mixture of basic ingredients and corn oil. 
1) Corn Oil Base: 
Casein--------------------------------585g 
Cellufil------------------------------135g 
Sucrose------------------------------2273g 
Salt Mix XX---------------------------ll1g 
*mixed in ball mill and then added: 
Vitamin Mix----------------------------68g 
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Corn Oil Diet: 
Corn Oil Base------------------------1000g 
Corn Oil------------------------------58ml 
2) SA-l Base: 
Casein--------------------------------820g 
Cellufil------------------------------640g 
Sucrose------------------------------2273g 
Salt Mix XX---------------------------156g 
Stearic Acid--------------------------631g 
*mixed in ball mill and then added: 
Vitamin Mix----------------------------86g 
SA-l Diet: 
SA-l Base----------------------------1000g 
Safflower Oil-------------------------l1ml 
3) SA-4 Base: 
This was made by adding Fat-Free Diet to the SA-1 base. 
SA-1 Base----------------------------4606g 
Fat-Free Diet------------------------1244g 
SA-4 Diet: 
SA-4 Base----------------------------1000g 
Safflower Oil-------------------------46ml 
4) Safflower Oil Diet: 
Fat-Free Mix--------------------------500g 
Safflower Oil-------------------------97ml 
5) Stock Diet: 
This diet consisted of Purina Rodent Chow from Ralston 
Purina Company, ST. Louis, MO .. 
Tumor Selection 
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Two types of tumors were removed from the mice for this 
project. Tumors were removed when they reached the 1 cm mark and 
some were also allowed to grow and were removed at a much larger 
size. This variation in tumor removal times allowed us to measure 
the fatty acid compositions of the membranes of large and small 
tumors. This made it possible to measure the difference in 
membranes at different stages of tumor growth. 
Isolation of Membranes 
The following procedure is a slight modification of Ray's 
( 20 ) • Once the tumors were obtained they were stored in .25% 
acetic acid and frozen until ready for use. When ready for 
isolation the tumor was thawed out and cut into slices of 2-3mm. 
The pieces were then suspended in isolation medium (.lM KHP04, pH 
7.4, 0.25M sucrose) and homogenized with a glass homogenizer. The 
connective tissue was removed by filtering the masserated sample 
through glass wool. 
The centrifugation process began at this point by first 
centrifuging the homogenate at 750xg for 10 minutes. The 
supernate was saved and the pellet was resuspended with isolation 
medium and centrifuged at 750xg for 10 minutes. The pellet was 
then discarded and the two supernates were mixed and centrifuged 
at 4000xg for 10 minutes. The supernate was discarded and the 
pellet was resuspended in 5-10ml calcium fortified buffer (2mM 
CaCl2 I 1mM NaHC03,pH 7.5). The calcium plays a key role in the 
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maintenance of structural and functional integrity of the membrane 
(21). The resuspended pellet was centrifuged at 1500xg for 10 
minutes. This centrifugation process was repeated two times and 
each time the supernate was discarded. The pellet could now be 
stored in 1.2ml of buffer or continued to the next step. 
Ultracentrifugation was the next step in plasma membrane 
isolation. One half milliliter of the previously stored pellet 
was removed and placed into an ultracentrifuge tube. one 
milliliter of 1.34 glml sucrose was added and the solution was 
mixed using a vortex mixer. 0.9ml of 1.20 g/ml sucrose was then 
added followed by 0.9ml of 1.18 glml sucrose and finally, 0.9ml of 
1.16 g/ml sucrose solution. The sample(s) was then placed in a 
swinging bucket rotor and centrifuged in a Beckman model L-50 
ultracentrifuge at 38,000 rpm for 90 minutes. 
After ultracentrifugation, the purified plasma membranes were 
located at the interface of the 1.18 glml and the 1.16 g/ml 
density layers. With a pasteur pipette, the membranes were gently 
removed and placed into a glass centrifuge tube. Equal amounts of 
buffer were added to each tube and the tubes were then vortexed. 
The solutions were then centrifuged at 5000xg for 10 minutes 
whereupon, the supernate was discarded and the pellet was 
resuspended in 2ml fortified buffer. The solution was again 
centrifuged but at 1500xg for 10 minutes. When the centrifugation 
was complete the supernate was discarded and the pellet that 
remained was the purified plasma membrane. The purified membrane 
was then resuspended in 0.25% acetic acid and then placed in a 
plas t conical storage container. The solution was then covered 
with nitrogen gas and placed in the freezer. 
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Saponification 
Plasma membrane fractions were placed in 15ml round bottom 
test tubes. Two milliliters of 15% KOH in 85% methanol was then 
added to each tube. The methanol was used to dissolve lipids. A 
marble was placed on every tube to prevent evaporation and the 
tubes were placed in a hot water bath at 85 C for 1 1/2 hours. 
The tubes were then removed from the hot water bath and HCl was 
added to make the solution acid to litmus. A white precipitate 
(KCl) was usually noted and small amounts of water were used to 
dissolve it. 
The saponification procedure allowed us to cleave fatty acids 
by a base catalyzed reaction. It also turned the fatty acids into 
a soap with the carboxyl group being soluble in water. The 
acidification process allowed us to convert the soap back into a 
fatty acid in preparation for extraction. 
Fatty Acid Extraction 
Hexane was added to each tube to dissolve the fatty acids and 
the solution was vortexed whereupon, the bottom aqueous layer was 
extracted using a pasteur pippette. An equal volume of saturated 
KCl was then added to each tube and this solution was mixed and 
the bottom aqueous layer was removed. Also, this process was 
performed twice to assure that only the fatty acids were being 
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extracted. A spatula tip full of Na2S0. was added to each tube 
and the tubes were mixed to remove any excess water. The contents 
were transfered to another tube where the solution was evaporated 
with nitrogen. 
Methylation 
Fatty acids were methylated by using a technique developed by 
Schlenk and Gellerman (21). The apparatus for this procedure 
consisted of two tubes with side arms. The arms were connected 
through rubber tubing to pasteur pippettes which were inserted 
through rubber stoppers to within 1 cm of the bottom of the tube. 
The first tube was also connected to a nitrogen source. The 
rubber tubing and pasteur pippette of the last tube were used to 
insert into the sample to be methylated. 
The first tube was filled with approximately 6ml of ether. 
The second tube contained 2ml carbitol and a mixture of 2ml 
Diazold and 2ml ether. The third tube consisted of the sample 
mixed with 5ml of ether:MeOH. The nitrogen flow rate was adjusted 
so that the stream would just make the ether bubble. 1-2ml of KOH 
was then added to the second tube to begin the base catalyzed 
reaction. Diazomethane was produced which changed our fatty acids 
into fatty acid methyl esters. The process was complete when 
there was an excess of diazomethane in the sample and the solution 
turned yellow. This procedure allowed us to make the fatty acids 
less polar which allowed them to move more quickly through the 
column of the Gas Chromatograph. 
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Gas-Liquid Chromatography 
The methyl esters of fatty acids extracted were identified 
using the Gas-Liquid Chromatograph (Varian 3600). The operating 
conditions were inlet temperature of 250 C, nitrogen flow rate of 
166.5 and column temperature of 195 C. Methyl esters of fatty 
acids were identified by comparing retention times with standard 
values Chromatographs were also produced by a varian 4290 
integrator. The integrator also recorded the retension time and 
area of each peak. The final identification of the fatty acids 
was done by using a conputer program, developed by Larry Bennett, 
which was based on peak retension times of fatty acids. 
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RESULTS AND CONCLUSIONS 
The fatty acid composition of plasma membranes of 24 tumors 
excised from animals on various diets were determined. Tumors 
were excised at two different stages. Some tumors were removed 
when they reached 1 cm in diameter and some were allowed to grow 
and were removed at a much larger stage. The following tumors 
were removed: 
1 . SA-1: 4 small, 3 large 
2 . CO: 5 small, 2 large 
3 . SA-4: 2 small, 1 large 
4. SAF: 3 small, 2 large 
5 . ST: 2 small 
Analysis of fatty acids of the various membrane fractions are 
listed in the appendix. Specific values for linoleic acid and 
stearic acid were calculated and compared. High fat diets such as 
SA-1, SA-4 and SAF varied in their stearic acid content. SA-4 
contained the highest amount of 18:0 with 24.1% in the small 
tumors and 16.9% in the large tumors as compared to 8.1% in the 
STOCK tumors. SAF and SA-1 membrane fractions were similar to 
each other in 18:0 concentrations. SAF contained an average of 
8.3% for small tumors and 12.6% for large tumors. SA-1 contained 
an average of 9.5% for small tumors and 10.9% for large tumors. 
Low fat diets such as the STOCK and CO diets did not differ very 
much from the SAF and SA-1 diet. 
The membrane fractions from the high fat and low fat diets 
17 
were extremely low in linoleic acid (18:2). The most linoleic 
acid detected in any of the samples was 3.5% which was obtained 
from the SAF large tumors. This value was only .8% higher than 
the 18:2 percentage in the STOCK tumors. On the other hand, The 
SAF small tumors did not contain any 18:2. The rest of the diets 
ranged from 0.1% to 1.9% which is below the 2.7% for STOCK tumors. 
When comparing the effects of the various diets on the fatty 
acid composition of the plasma membrane it can be shown that the 
SA-4 diet produces a decrease in the amount of 18:2 and a drastic 
increase in the amount of 18:0 and 22:2 in the membrane. SAF 
large tumors also showed an increase in 18:0. The CO diet 
produced a tremendous decrease in the amount of 18:2 and all the 
other tumors from the various diets, except SAF large tumors, also 
showed a decrease in 18:2 concentration. 
These results indicate that high fat diets increase the 
utilization of stearic acid in the development of plasma 
membranes. High fat diets may also increase tumorogenesis by 
decreasing the amount of polyunsaturated fats used for membrane 
development and therefore, decreasing the fluidity of the 
membrane. Low fat diets showed a small increase in stearic acid 
utilization and a decrease in linoleic acid utilization. Since 
the membranes from the mice fed a low fat diet contained less 
stearic acid, they should be more fluid than the membranes from the 
mice fed high fat diets thus less tumorogenic. The large decrease 
in linoleic acid may be attributed to early activities in tumor 
development such as prostaglandin development. 
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FATTY ACID CONTENT(%) FOR LARGE TUMORS 
********************************************************************** 
* high fat low fat * 
* 
* SAF 
* 
* 16:0 15.5~3.60 
* 
* 16:1 5.80~2.25 
* * 16:2 0.95~0.95 
* 
* 18:0 12.6+3.35 
* 
* 18:1 16.2~1.25 
* 
* 18:2 3.50~1.30 
* * 18:3 0 
* * 18:7 0 
* * 22:1 0.80±0.80 
* * 22:2 1.90+0.30 
* 
* 22:3 0 
* * 22:4 0.30~0.30 
* 
* 22:6 1 0 
SA-4 
21.4 
4.6 
o 
16.9 
10.6 
1.9 
o 
o 
5.0 
6.8 
o 
o 
o 
SA-1 
16.4~4.63 
1.80+1.29 
10.9+3.87 
7.80+2.61 
1. 80~. 189 
o 
o 
o 
6.70~4.12 
o 
o 
o 
CO 
14.8~0.2 
5.10±0.1 
o 
8.70~0.8 
5.20±1.30 
0.60+0.55 
o 
o 
o 
3.80±0.95 
o 
o 
2.70+2.70 
* 
* 
* 
* 
* 
* 
* 
* 
* 
* 
* 
* 
* 
* 
* 
* 
* 
* 
* 
* 
* 
* 
* 
* 
* 
* 
* 
* ********************************************************************** 
1The first number equals the number of carbon molecules and the 
second number is the number of double bonds. 
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-FATTY ACID CONTENT(%) FOR SMALL TUMORS 
*********************************************************************** 
* high fat low fat * 
* * 
* SAF 
*16:0 13.8±.4.19 
* *16:1 2.40±.1.85 
* *16:2 1.10±.1.60 
* 
*18:0 8.30±..736 
* 
*18:1 3.90±..822 
* 
*18:2 0 
* 
*18:3 0 
* 
*18:7 0 
* *22:1 .230+.329 
* *22:2 2.40±.1.39 
* *22:3 0 
1:l2:4 0 
* 
*22:6 1 0 
SA-4 
24.3+0.80 
1.90+1.85 
o 
24.1±.9.05 
5.20±.2.35 
0.60±.0.60 
o 
o 
0.70+0.70 
9.30+6.55 
o 
o 
o 
SA-l 
17.1+5.24 
2.80+2.84 
1.70±.2.81 
9.50±.2.22 
6.50±.1.91 
1.80±.2.77 
.480±..822 
.730+1.26 
o 
~. TO±.1 • 38 
o 
o 
o 
CO 
14.6±.4.49 
4.90±.2.32 
o 
9.80±.3.43 
5.40±.2.32 
0.10±.0.20 
o 
o 
.660±.1.32 
2.20±.1.12 
o 
o 
o 
STOCK * 
14.7±_3.75 * 
* 4.10±.1.00 * 
* 
1.10+1.10 * 
* 8.10±.1.45 * 
* 
6.50±.0.70 * 
* 
2.70+0.95 * 
* 
o * 
* 
o * 
* 0.10+0.10* 
* 3.90±..450 * 
* 0.05+0.05 * 
* 
o * 
* 
o * 
*********************************************************************** 
1The first number equals the number of carbon molecules and the 
second number is the number of double bonds. 
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SUMMARY 
The plasma membrane fractions that were analyzed showed an 
interesting variance in the amount of 18:0 and 18:2. SA-4 showed 
a quite large percentage of 18:0 and a very low percentage of 
18:2. All the tumors showed an increase in the amount of 18:0 as 
compared to the STOCK diet tumors. All the tumors also showed 
a decrease in the amount of 18:2 except the SAF large tumors which 
had a very small increase. These results indicate that the 
linoleic acid must be being used elsewhere with stearic acid being 
used to develop the plasma membranes. 
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-APPENDIX 
-FATTY ACID CONTENT(%) FOR SAF 
********************************************************************************* 
* * 
* SAF small SAF large * 
* * 
* q23 q24 q44 AVERAGE q48 q33 AVG * 
*16:0 13.6 9.5 18.4 13.8±.4.19 11.9 19.1 15.5±.3.60 * 
* * 
*16:1 4.5 0 2.8 2. 4±.1. 85 3.5 8.0 5.8±.2.25 * 
* * 
*16:2 0 3.4 0 1.1±.1.60 0 1.9 . 95±.. 95 * 
* * 
*18:0 7.4 8.2 9.2 8.3±..736 9.2 15.9 12.6±.3.35 * 
* * 
*18:1 4.1 2.9 4.9 3.9±..822 4.9 7.4 6. 2±.1. 25 * 
* * 
*18:2 0 0 0 0 2.2 4.8 3.5±.1.30 * 
* * 
*18:3 0 0 0 0 0 0 0 * 
* * 
*18:7 0 0 0 0 0 0 0 * 
* * 
*22:1 0 0.7 0 .23±..329 0 1.6 • 8±.. 80 * 
* * 
*22:2 3.4 0.4 3.3 2. 4±.1. 39 1.6 2.2 1.9±..30 * 
* * 
*22:3 0 0 0 0 0 0 0 * 
* * 
*22:4 0 0 0 0 0.6 0 0.3±.0.3 * 
* * 
*22:6 1 0 0 0 0 0 0 0 * 
********************************************************************************* 
IThe first number equals the number of carbon molecules and the second 
number is the number of double bonds. 
,-
-FATTY ACID CONTENT(%) FOR SA-4 
********************************************************************************* 
* * 
* 
* 
* q27 
*16:0 25.1 
* *16:1 0 
* *16:2 0 
* *18:0 33.1 
* *18:1 2.8 
* *18:2 0 
* *18:3 0 
* *18:7 0 
* *22:1 0 
* *22:2 2.7 
* *22:3 0 
* *22:4 0 
* *22:6 1 0 
SA-4 small 
q29 
23.5 
3.7 
o 
15.0 
7.5 
1.2 
o 
o 
1.4 
15.8 
o 
o 
o 
AVERAGE 
24.3±.0.8 
1. 9±.1. 85 
o 
24.1±.9.05 
5.2±.2.35 
0.6±.0.6 
o 
o 
0.7±.0.7 
9.3±.6.55 
o 
o 
o 
SA-4 large 
q35 
21.4 
4.6 
o 
16.9 
10.6 
1.9 
o 
o 
5.0 
6.8 
o 
o 
o 
* 
* 
* 
* 
* 
* 
* 
* 
* 
* 
* 
* 
* 
* 
* 
* 
* 
* 
* 
* 
* 
* 
* 
* 
* 
* 
* 
* ********************************************************************************* 
1The first number equals the number of carbon molecules and the second 
number is the number of double bonds. 
-FATTY ACID CONTENT(%) FOR SA-1 
********************************************************************************* 
* * 
* SA-I small SA-1 large * 
* * 
* q7 q8 q30 q43 AVERAGE q11 q12 q31 AVG * 
*16:0 9.2 23.9 18.2 17.0 17.1±5.24 13.4 12.8 22.9 16.4±4.63 * 
* * 
*16:1 0 0 6.1 5.2 2.8±2.84 4.3 4.4 6.4 5.0+.967 * 
* * 
*16:2 6.5 0 0 0 1.7±2.81 2.8 2.7 0 1. 8±1. 29 
* 
* * 
*18:0 6.5 11.1 12.1 8.3 9.5±2.22 9.0 7.4 16.3 10.9±3.87 * 
* * 
*18:1 4.8 9.2 7.4 4.6 6.5±1.91 5.1 7.3 11.4 7.8±2.61 * 
* * 
*18:2 0 6.6 0.7 0 1.8±2.77 2.1 1.7 1.7 1. 8±. 189 * 
* * 
*18:3 0 1.9 0 0 .48±.822 0 0 0 0 * 
* * 
*18:7 0 2.9 0 0 .73±1.26 0 0 0 0 * 
* * 
*22:1 0 0 0 0 0 0 0 0 0 * 
* * 
*22:2 0.3 3.8 3.3 3.2 2.7±1.38 4.3 3.3 12.5 6.7±4.12 * 
* * 
*22:3 0 0 0 0 0 0 0 0 0 * 
* * 
*22:4 0 0 0 0 0 0 0 0 0 * 
* * 
*22:6 1 0 0 0 0 0 0 0 0 0 * 
********************************************************************************* 
1 The first number equals the number of carbon molecules and the second 
number is the number of double bonds. 
,-
FATTY ACID CONTENT(%) FOR CO 
********************************************************************************* 
* * 
* CO small CO large * 
* * 
* q22 q25 q26 q46 q47 AVERAGE q34 q37 AVG * 
*16:0 9.4 16.7 22.2 13.0 11.6 14.6±4.49 15.0 14.6 14.8±0.2 * 
* * 
*16:1 4.3 9.5 3.4 3.8 3.5 4.9±2.32 5.0 5.2 5.1±0.1 * 
* * 
*16:2 0 0 0 0 0 0 0 0 0 * 
* * 
*18:0 5.4 13.1 14.5 8.7 7.5 9.8±3.43 9.5 7.9 8.7 ±O. 8 * 
* * 
*18:1 6.5 4.4 1.4 8.1 6.6 5.4±2.32 3.9 6.5 5. 2±1. 3 * 
* * 
*18:2 0 0 0 0 0.5 0.1±0.2 0 1.1 0.6±.55 * 
* * 
*18:3 0 0 0 0 0 0 0 0 0 * 
* * 
*18:7 0 0 0 0 0 0 0 0 0 * 
* * 
*22:1 0 0 3.3 0 0 . 66±1. 32 0 0 0 * 
* * 
*22:2 4.1 1.2 0.9 2.3 2.3 2.2±1.12 4.7 2.8 3.8±.95 * 
* * 
*22:3 0 0 0 0 0 0 0 0 0 * 
* * 
*22:4 0 0 0 0 0 0 0 0 0 * 
* * 
*22:6 1 0 0 0 0 0 0 5.3 0 2. 7±2. 7 * 
********************************************************************************* 
lThe first number equals the number of carbon molecules and the second 
number is the number of double bonds. 
,-
FATTY ACID CONTENT(%) STOCK 
********************************************************************************* 
* * 
* STOCK * 
* * 
* q5 q6 AVERAGE * 
*16:0 10.9 18.4 14.7±3.75 * 
* * 
*16:1 3.1 5.1 4. 1±1. 00 * 
* * 
*16:2 2.1 0 1. 1±1. 10 * 
* * 
*18:0 6.6 9.5 8. 1±1. 45 * 
* * 
*18:1 5.8 7.2 6.5±0.70 * 
* * 
*18:2 3.6 1.7 2.7±0.95 * 
* * 
*18:3 0 0 0 * 
* * 
*18:7 0 0 0 * 
* * 
*22:1 0.2 0 0.1±0.10 * 
* * 
*22:2 4.4 3.5 3.9±.450 * 
* * 
*22:3 0.1 0 0.05±0.05 * 
* * 
*22:4 0 0 0 * 
* * 
*22:6 1 0 0 0 * 
********************************************************************************* 
lThe first number equals the number of carbon molecules and the second 
number is the number of double bonds. 
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